These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28224249)

  • 1. Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH
    Takkis K; Aro R; Kõrgvee LT; Varendi H; Lass J; Herodes K; Kipper K
    Anal Bioanal Chem; 2017 May; 409(12):3145-3151. PubMed ID: 28224249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples.
    Sora DI; Udrescu S; Albu F; David V; Medvedovici A
    J Pharm Biomed Anal; 2010 Sep; 52(5):734-40. PubMed ID: 20307949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples.
    Sandall JM; Millership JS; Collier PS; McElnay JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 839(1-2):36-44. PubMed ID: 16510319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS.
    Dong H; Xu F; Zhang Z; Tian Y; Chen Y
    J Mass Spectrom; 2006 Apr; 41(4):477-86. PubMed ID: 16541392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
    Steimer W; Müller C; Eber B
    Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a fast and sensitive UHPLC-ESI-MS method for the simultaneous quantification of spironolactone and its metabolites in ocular tissues.
    Dahmana N; Gabriel D; Gurny R; Kalia YN
    Biomed Chromatogr; 2018 Oct; 32(10):e4287. PubMed ID: 29767448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry.
    Jones SM; Kirkwood-Donelson KI; Alexander GM; Perera L; Dudek SM; Jarmusch AK
    Rapid Commun Mass Spectrom; 2024 Aug; 38(15):e9775. PubMed ID: 38807480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of spironolactone and its metabolites in human plasma.
    Jankowski A; Skorek-Jankowska A; Lamparczyk H
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1359-65. PubMed ID: 8818057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
    Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
    J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A; Johnson MJ
    J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of age and multimorbidity on the pharmacokinetics and metabolism of spironolactone.
    Platt D; Abshagen U; Mühlberg W; Horn HJ; Schmitt-Rüth R; Vollmar J
    Arch Gerontol Geriatr; 1984 Jul; 3(2):147-59. PubMed ID: 6476975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of HPLC-ESI-MS method for the determination of eplerenone in human plasma and its pharmacokinetics.
    Qian WJ; Ding L; Wen AD; Gong B; Leng Y; Yun CH; Yang L
    Yao Xue Xue Bao; 2009 Jul; 44(7):771-7. PubMed ID: 19806919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum.
    Kaukonen AM; Vuorela P; Vuorela H; Mannermaa JP
    J Chromatogr A; 1998 Feb; 797(1-2):271-81. PubMed ID: 9542120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENVIRONMENTALLY FRIENDLY LC/MS DETERMINATION OF EPLERENONE IN HUMAN PLASMA.
    Bus-Kwasnik K; Filist M; Rudzki PJ
    Acta Pol Pharm; 2016 Nov; 73(6):1487-1493. PubMed ID: 29634102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.
    Ho PC; Bourne DW; Triggs EJ; Heazlewood V
    Eur J Clin Pharmacol; 1984; 27(4):441-6. PubMed ID: 6519151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput quantification of 8 antihypertensive drugs and active metabolites in human plasma using UPLC-MS/MS.
    van der Nagel BCH; Versmissen J; Bahmany S; van Gelder T; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():367-373. PubMed ID: 28666228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography.
    Krause W; Karras J; Jakobs U
    J Chromatogr; 1983 Oct; 277():191-9. PubMed ID: 6643605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume.
    Xu Y; Yuan Y; Smith L; Edom R; Weng N; Mamidi R; Silva J; Evans DC; Lim HK
    J Pharm Biomed Anal; 2013 Nov; 85():145-54. PubMed ID: 23948760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
    Los LE; Coddington AB; Ramjit HG; Colby HD
    Drug Metab Dispos; 1993; 21(6):1086-90. PubMed ID: 7905388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.